Spanish Red Biotech Pipeline

Amgen

acapatamab

Type: Biodrugs/ Drugs
Therapeutic area: Cancer
Indication: Metastatic castration-resistant prostate cancer (mCRPC)
Phase: 2Phase II in Spain, 1Phase I in Spain